Biggest News Aggregation in the World
📰 General Practice News

Page 93 - General Practice News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from General Practice. Real-time updates on events, politics, business and more.

BBCNEWS BBC News February 7, 2022 15:14:00

Useful. but we do need to match that online support with a more practical off—line support. for those people who are facing these long waits, and that means boasting general practice, community services, and a social care to make sure that people stay as healthy as possible while they wait —— means boosting general practice, community service and social care. and give them a place to go if they have a problem that cannot wait-— to go if they have a problem that cannot wait. ., ,, i. ., ,...
General Practice Community Services Community Service Cannot Wait Guto Harri Prime Minister

BBCNEWS BBC News March 30, 2022 16:39:00

Driver behind this drop in satisfaction.— driver behind this drop in satisfaction. ., . satisfaction. to what extent did 0 - inion satisfaction. to what extent did opinion vary — satisfaction. to what extent did opinion vary according - satisfaction. to what extent did opinion vary according to - satisfaction. to what extent did opinion vary according to age i satisfaction. to what extent did | opinion vary according to age or income or your political allegiance? well, there is no single sor...
General Practice Services Including Men And Women

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Frontiers | Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition

Autoimmune toxicities, while common following treatment with cancer immunotherapies, are not well-characterized in patients treated with BRAF/MEK inhibitors. Emerging data suggest that autoimmune effects may be linked with superior responses to both treatment modalities; however, there is little evidence describing mechanisms of immune-related toxicity for patients on BRAF/MEK inhibitors. Here we describe the experience of a 59-year-old HLA-A2, A29, B27-positive male patient with recurrent/metas...
Chiarion Sileni Yehs Vogt Koyanagi Harada Brafi Meki Homet Moreno Dummerr Development Of Encorafenib Uveitis Study Group

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science